Jorgen Jahnsen

Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 109 publications

Anti-TNF withdrawal or long-term treatment in ulcerative colitis (BIOSTOP): a multicentre open label, randomized controlled trial.

Anti-TNF withdrawal or long-term treatment in ulcerative colitis (BIOSTOP): a multicentre open label, randomized controlled trial.

Journal: Journal of Crohn's & colitis

Published: August 06, 2026

High-dose intravenous iron improves quality of life in patients with inflammatory Bowel disease and iron deficiency.

High-dose intravenous iron improves quality of life in patients with inflammatory Bowel disease and iron deficiency.

Journal: Scandinavian journal of gastroenterology

Published: January 03, 2026

High consumption of risk medication and underutilization of proton pump inhibitors among patients with upper gastrointestinal bleeding due to peptic ulcers and erosions (BLUE study).

High consumption of risk medication and underutilization of proton pump inhibitors among patients with upper gastrointestinal bleeding due to peptic ulcers and erosions (BLUE study).

Journal: Scandinavian journal of gastroenterology

Published: December 16, 2025

Cost-effectiveness of proactive therapeutic drug monitoring of maintenance infliximab treatment in patients with immune-mediated inflammatory diseases: results from a randomised controlled trial.

Cost-effectiveness of proactive therapeutic drug monitoring of maintenance infliximab treatment in patients with immune-mediated inflammatory diseases: results from a randomised controlled trial.

Journal: RMD open

Published: September 08, 2025

Multi-centered T cell repertoire profiling identifies alterations in the immune repertoire of individuals with inflammatory bowel disease across different disease stages.

Multi-centered T cell repertoire profiling identifies alterations in the immune repertoire of individuals with inflammatory bowel disease across different disease stages.

Journal: Genome medicine

Published: June 24, 2025

Iron deficiency should not be accepted in patients with inflammatory bowel disease - a Scandinavian expert opinion.

Iron deficiency should not be accepted in patients with inflammatory bowel disease - a Scandinavian expert opinion.

Journal: Scandinavian journal of gastroenterology

Published: April 09, 2025

Treatment discontinuation rates due to lack of efficacy through 1 year of maintenance treatment with vedolizumab or subcutaneous infliximab in patients with inflammatory bowel disease: a systematic literature review and meta-analysis.

Treatment discontinuation rates due to lack of efficacy through 1 year of maintenance treatment with vedolizumab or subcutaneous infliximab in patients with inflammatory bowel disease: a systematic literature review and meta-analysis.

Journal: Therapeutic advances in gastroenterology

Published: March 10, 2025

Microbial Patterns in Newly Diagnosed Inflammatory Bowel Disease Revealed by Presence and Transcriptional Activity - Relationship to Diagnosis and Outcome.

Microbial Patterns in Newly Diagnosed Inflammatory Bowel Disease Revealed by Presence and Transcriptional Activity - Relationship to Diagnosis and Outcome.

Journal: Clinical and experimental gastroenterology

Published: November 06, 2024

Extracorporeal Photopheresis with 5-Aminolevulinic Acid in Crohn's Disease-A First-in-Human Phase I/II Study.

Extracorporeal Photopheresis with 5-Aminolevulinic Acid in Crohn's Disease-A First-in-Human Phase I/II Study.

Journal: Journal of clinical medicine

Published: September 24, 2024

Deficient SARS-CoV-2 hybrid immunity during inflammatory bowel disease.

Deficient SARS-CoV-2 hybrid immunity during inflammatory bowel disease.

Journal: Clinical immunology (Orlando, Fla.)

Published: August 14, 2024

Humoral and cellular responses to a fifth bivalent SARS-CoV-2 vaccine dose in patients with immune-mediated inflammatory diseases on tumour necrosis factor inhibitors: a prospective cohort study.

Humoral and cellular responses to a fifth bivalent SARS-CoV-2 vaccine dose in patients with immune-mediated inflammatory diseases on tumour necrosis factor inhibitors: a prospective cohort study.

Journal: The Lancet regional health. Europe

Published: August 05, 2024

Exploring alterations in the gut resistome in medically treated inflammatory bowel disease patients.

Exploring alterations in the gut resistome in medically treated inflammatory bowel disease patients.

Journal: BMC microbiology

Published: May 01, 2024

Showing 1-12 of 109

Last Updated: 09/26/2026